Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Belmac is a prominent Spanish pharmaceutical company specializing in the development, manufacture, and distribution of generic medicines. As a key subsidiary of the Alter Group (Grupo Alter), the company plays a vital role in the Spanish healthcare system by providing high-quality, affordable therapeutic alternatives. Its extensive product portfolio covers a wide range of therapeutic areas, including cardiology, gastroenterology, central nervous system disorders, and anti-infectives. Operating from its headquarters in Madrid, Belmac utilizes advanced manufacturing facilities to produce a variety of oral solid dosage forms. The company is recognized for its long-standing commitment to the retail pharmacy sector and its contribution to the sustainability of public health spending through generic substitution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Belmac.